K. Asadi

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer

I. Nagtegaal, J. Mariadason, J. Simes, 2015, British Journal of Cancer.

Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer (mCRC): Analysis of the phase III MAX study.

J. Mariadason, J. Simes, T. Price, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Spatial-temporal dynamics of pulmonary blood flow in the healthy human lung in response

R. Glenny, R. Buxton, G. Drummond, 2015 .

The Immune Microenvironment, Genome‐wide Copy Number Aberrations, and Survival in Mesothelioma

P. Boutros, B. Thapa, A. Salcedo, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.